Breaking News
Get 40% Off 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Doximity Inc (DOCS)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Doximity's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
24.82 -0.37    -1.47%
18/04 - Closed. Currency in USD ( Disclaimer )
After Hours
24.80
-0.02
-0.10%
0:00:00 - Real-time Data
  • Volume: 1,210,714
  • Bid/Ask: 24.49 / 25.24
  • Day's Range: 24.80 - 25.46
Type:  Equity
Market:  United States
Doximity 24.82 -0.37 -1.47%

Doximity Company Profile

 
Read the Doximity Inc company profile to learn more about the business and the management team. View Doximity Inc facts about employee data, company products and services, and contact information.
IndustrySoftware & IT Services
SectorTechnology
Employees

973

Equity Type

ORD

Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company’s platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical manufacturers and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.

Contact Information

Address 500 3rd Street Suite 510
San Francisco, 94107
United States
Phone 650 549 4330
Fax -

Top Executives

Name Age Since Title
Michael Alan Nierenberg - - Member of Medical Advisory Board
Kevin Spain 51 2011 Independent Director
Harvey Abraham Fishman - - Member of Medical Advisory Board
Daniel Lewis Kraft - - Member of Medical Advisory Board
Jeffrey A. Tangney 50 2010 Co-Founder, CEO & Chairperson
Barry Paul Chaiken - - Member of Medical Advisory Board
Alan Rustin Greene - - Member of Medical Advisory Board
Frederick Hofheinz - - Member of Medical Advisory Board
Leslie S. Kardos - - Member of Medical Advisory Board
Peter C. Schalock - - Member of Medical Advisory Board
E. Rand Sutherland - - Member of Medical Advisory Board
Paul J. Turek - - Member of Medical Advisory Board
Christopher A. Longhurst - - Member of Medical Advisory Board
Howard Luks - - Member of Medical Advisory Board
Neil H. Stollman - - Member of Medical Advisory Board
Bradley R. Cohn - - Member of Medical Advisory Board
Joseph Kim - - Member of Medical Advisory Board
Irving Kent Loh - - Member of Medical Advisory Board
Lauren D. Stegman - - Member of Medical Advisory Board
Lawrence Matthew Tierney - - Member of Medical Advisory Board
Lawrence S. Chin - - Member of Medical Advisory Board
Joseph I. Sirven - - Member of Medical Advisory Board
Pierre R. Theodore - - Member of Medical Advisory Board
Wendy Sue L. Swanson - - Member of Medical Advisory Board
David Toub - - Member of Medical Advisory Board
Felasfa Mulugeta Wodajo - - Member of Medical Advisory Board
Todd A. Ferris - - Member of Medical Advisory Board
Sanjay K. Saint - - Member of Medical Advisory Board
Timothy Stephen Cabral 56 2020 Independent Director
Elise Michele Brett - - Member of Medical Advisory Board
Lewis Wexler - - Member of Medical Advisory Board
Lawrence R. Lustig - - Member of Medical Advisory Board
Joshua Adam Schwimmer - - Member of Medical Advisory Board
Bryan Vartabedian - - Member of Medical Advisory Board
Alexander Ding - - Member of Medical Advisory Board
Mark D. Price - - Member of Medical Advisory Board
Connie Savor Price - - Member of Medical Advisory Board
Michael A. Thompson - - Member of Medical Advisory Board
Vikas Jain - - Member of Medical Advisory Board
Kira Scherer Wampler 50 2020 Independent Director
Leslie Andrew Lenert - - Member of Medical Advisory Board
Jordan L. Shlain - - Member of Medical Advisory Board
Rafael Lugo - - Member of Medical Advisory Board
Nancy Ann Shadick - - Member of Medical Advisory Board
Sharon Sookdeo Drost - - Member of Medical Advisory Board
Regina Marcia Benjamin 67 2020 Independent Director
Phoebe L. Yang Watkin 54 2022 Independent Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

DOCS Price Commentary

Write your thoughts about Doximity Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email